News
Silver Export Award presented to AOP Orphan
9. 4. 2021AOP Orphan reports full validity of arbitral award against PharmaEssentia
25. 3. 2021Health Europe: AOP Orphan a European pioneer in the field of rare and complex diseases
18. 3. 2021
Science & Innovation
From the Concept to the Drug
AOP Orphan headquarters team covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.
CONNECTED WORLDWIDE
Partnering
Partnering is of key importance for AOP Orphan. It allows further developing AOP Orphan’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe. Find out more about the cooperation opportunities with AOP Orphan headquarters using the link below.